Actively Recruiting
Autologous Ovarian Tissue Transplantation
Led by University of Pittsburgh · Updated on 2025-08-14
5
Participants Needed
1
Research Sites
339 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Chemotherapy and radiation for cancer and other conditions can cause infertility. Several centers around the world are cryopreserving ovarian tissue from these patients though an experimental protocol, including the Fertility Preservation Program in Pittsburgh (protocol PRO08050491). The objective of this study is to study the efficacy and safety of autologous tissue transplantation in patients diagnosed with primary ovarian insufficiency after chemotherapy and/or radiation treatments.
CONDITIONS
Official Title
Autologous Ovarian Tissue Transplantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Previously cryopreserved ovarian tissue
- Diagnosis of ovarian insufficiency and/or being a candidate for pregnancy
- Good general health
- Clearance from oncologist to participate
You will not qualify if you...
- High risk for surgical complications
- Contraindications to pregnancy if pregnancy is a study goal
- Positive for BRCA mutations
- History of leukemia, ovarian cancer, or cancers likely involving ovaries when tissue was collected
- Psychological or psychiatric conditions preventing informed consent
- Current pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Magee-Womens Hospital
Pittsburgh, Pennsylvania, United States, 15213
Actively Recruiting
Research Team
J
Jennifer Anglin
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here